

The abstract of the publication detailing the results of the VITROCARD-0001 clinical study for VitroGro® ECM.
![]()
During the 2011-12 financial year, some of the most important final milestones necessary for the sales launch of VitroGro® ECM were successfully completed. Please download the report for details.
![]()
This publication highlights the requirements for an extracellular matrix (ECM) replacement therapy for the treatment of hard to heal wounds which compare favourably to the design and use of VitroGro® ECM.
![]()
Documents the high cost of Venous Leg Ulcers supporting the need for a cost effective treatment that can reduce the burden on the healthcare community.
![]()
Details the spiraling costs for treating hard to heal wounds and support the need for a product like VitroGro® ECM.
![]()
Related Content